Monodisperse Polyethylene glycol (PEG) has long been widely used in nanoformulations to improve solubility and biocompatibility in pharmaceutical systems.

At the same time, monodisperse Polypropylene Glycol (PPG) is attracting increasing interest as a potential alternative material, particularly for hydrophobic drug delivery.

Why is this interesting?

PPG possesses a unique molecular duality: a hydrophilic ether group in its backbone that can form hydrogen bonds, combined with hydrophobic methyl side groups. This balance between hydrophilic and hydrophobic interactions allows PPG to respond dynamically to changes in its environment.

At certain temperatures, PPG can transition from a soluble to a phase-separated state — a hallmark of LCST behavior. Such responsiveness may support controlled drug release, self-assembly into nanostructures such as micelles and nanogels, and the development of smart responsive materials.

Molecular weight plays an important role in this behavior. Lower molecular weight PPGs have been observed to remain water-soluble while exhibiting LCST transitions in aqueous systems. In contrast, higher molecular weight variants often display LCST values below room temperature, significantly influencing their behavior and formulation potential.

Beyond water-based systems, LCST behavior has also been observed in ionic liquids, opening additional opportunities for formulation science. Recent studies have even reported unexpected co-solvency effects, where small amounts of water influence PPG solubility in ionic liquid systems and alter LCST behavior in meaningful ways.

Why is it not used now?

One of the key barriers to broader biomedical use of PPG has been material consistency. Conventional commercial PPG often contains compositional variability and unsaturated impurities, creating challenges for reproducibility in sensitive applications.

As part of an internal research initiative, Polypure has developed a high-purity, monodisperse PPG designed to address these limitations and support further research into advanced drug delivery systems.

The question now becomes: could high-purity monodisperse PPG emerge as an important next-generation material platform for nanoformulations?

DrugDelivery #Nanomedicine #PolymerScience #Biomaterial

Poly(ethylene glycol) (PEG) is one of the most widely used polymers in pharmaceuticals and personal care applications, playing a key role as a surfactant, emulsifier, and in drug delivery systems by improving solubility and extending circulation time. However, standard PEG is typically polydisperse, consisting of mixtures of different chain lengths that can introduce variability in analysis, reproducibility, and formulation performance.

https://www.chemistryworld.com/industry/advantages-of-monodisperse-peg-in-drug-development/4023224.article